|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.860 USD | +8.03% |
|
+12.27% | +122.01% |
| 06-30 | Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russell 3000 Value Index | CI |
| 06-30 | Tango Therapeutics, Inc.(NasdaqGM:TNGX) added to Russell 2500 Value Index | CI |
| Capitalization | 744M 642M 598M 554M 1.02B 63.97B 1.15B 7.25B 2.73B 29.96B 2.79B 2.73B 110B | P/E ratio 2025 * |
-5.17x | P/E ratio 2026 * | -5.34x |
|---|---|---|---|---|---|
| Enterprise value | 744M 642M 598M 554M 1.02B 63.97B 1.15B 7.25B 2.73B 29.96B 2.79B 2.73B 110B | EV / Sales 2025 * |
25.7x | EV / Sales 2026 * | 25.3x |
| Free-Float |
87.16% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Tango Therapeutics, Inc.
More recommendations
More press releases
| 1 day | +8.03% | ||
| 1 week | +12.27% | ||
| Current month | +33.98% | ||
| 1 month | +42.77% | ||
| 3 months | +431.78% | ||
| 6 months | +140.70% | ||
| Current year | +122.01% |
| 1 week | 5.83 |  | 6.96 |
| 1 month | 4.6 | | 6.96 |
| Current year | 1.03 | | 6.96 |
| 1 year | 1.03 | | 12.02 |
| 3 years | 1.03 | | 13.03 |
| 5 years | 1.03 | | 18.84 |
| 10 years | 1.03 | | 18.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Barbara Weber
CEO | Chief Executive Officer | 68 | 2017-02-28 |
Daniella Beckman
DFI | Director of Finance/CFO | 46 | 2016-09-30 |
Jannik Andersen
CTO | Chief Tech/Sci/R&D Officer | - | 2023-10-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Barbara Weber
BRD | Director/Board Member | 68 | 2017-02-28 |
Alexis Borisy
CHM | Chairman | 53 | - |
Malte Peters
BRD | Director/Board Member | 62 | 2018-08-31 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0% | 9 M€ | +5.66% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.03% | +12.27% | -29.71% | +52.11% | 744M | ||
| +0.02% | +1.21% | +10.28% | +1.46% | 50.03B | ||
| +4.01% | +14.59% | +88.98% | +63.90% | 34.39B | ||
| +2.04% | +1.01% | +2.34% | +9.85% | 28.64B | ||
| +2.91% | -1.38% | -29.11% | -25.48% | 28.24B | ||
| +0.56% | +0.56% | +25.37% | -22.29% | 12.59B | ||
| +1.97% | -3.41% | -56.01% | -30.43% | 11.67B | ||
| +1.03% | +0.40% | +27.88% | +107.66% | 10.73B | ||
| +1.13% | +1.76% | +52.20% | - | 10.5B | ||
| -0.12% | -0.64% | +10.40% | -3.12% | 10.45B | ||
| Average | +1.98% | +2.47% | +10.26% | +17.07% | 19.8B | |
| Weighted average by Cap. | +1.37% | +2.44% | +17.27% | +12.58% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 28.92M 24.95M 23.27M 21.56M 39.76M 2.49B 44.61M 282M 106M 1.16B 108M 106M 4.29B | 29.45M 25.41M 23.7M 21.96M 40.48M 2.53B 45.42M 287M 108M 1.19B 110M 108M 4.37B |
| Net income | -153M -132M -123M -114M -211M -13.18B -236M -1.49B -563M -6.17B -575M -563M -22.75B | -180M -155M -145M -134M -247M -15.46B -277M -1.75B -660M -7.24B -674M -660M -26.69B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
155
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-17 | 6.860 $ | +8.03% | 1,682,462 |
| 25-07-16 | 6.350 $ | +7.45% | 2,426,803 |
| 25-07-15 | 5.910 $ | -2.96% | 1,484,614 |
| 25-07-14 | 6.090 $ | +2.70% | 1,407,159 |
| 25-07-11 | 5.930 $ | -2.95% | 1,382,331 |
Delayed Quote Nasdaq, July 17, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
6.860USD
Average target price
10.43USD
Spread / Average Target
+52.02%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TNGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition